Gelteq Limited GELS

Full chart Compare

Set alert

0.42 USD 0.00 (+0.14%)

At closeNov 11, 2026, 4:20 PM EST

0.44 +0.02 +3.64%

After hours · Nov 11, 4:20 PM ET

0.415 Day range 0.4306

0.387 52-week range 2.01

YTD: -47.41%
1 year: -61.05%

Market cap: 4.51M
Revenue (ttm): 131.76K
EPS (ttm): -0.44
Shares out: 9.44M
YTD return: -47.41%
1-year return: -61.05%

Volume: 31.44K
Avg volume: 2.85M
Open: 0.4202
Previous close: 0.4201
Day's range: 0.415 – 0.4306
52-week range: 0.387 – 2.01

1D 5D 1M 3M 6M YTD 1Y 2Y 5Y MAX ALL

Customize chart

5D -0.0409 (-8.87%)

Enterprise value: 15.48M
PEG ratio: 0.00
Price / sales: 174.07
Price / book: 1.21
Dividend yield: 0.00%
Payout ratio: 0.00%
Revenue growth: -68.90%
Free cash flow: -463.50K
Total cash: 399.22K
Total debt: 2.49M
Return on equity: -18.75%
Short % of float: 0.00%
50-day average: 2.45
200-day average: 2.45

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

GELS Revenue — quarterly 0

GELS Net income — quarterly -1.13M

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Australia
Website: gelteq.com

Gelteq Limited GELS

Key statistics

Next earnings

Financials — quick view

About Gelteq Limited

News

Your note